Navigation Links
TB Alliance Appoints Willo Brock Senior Vice President, External Affairs
Date:7/31/2014

NEW YORK, July 31, 2014 /PRNewswire-USNewswire/ -- TB Alliance, a not-for-profit with the mission of discovering and developing better, faster and affordable treatments, announced the appointment of Willo Brock as Senior Vice President, External Affairs. Mr. Brock comes to TB Alliance having most recently served as Head of Major Donor Relations for WWF International (formerly known as the World Wildlife Fund). In his role, Mr. Brock will guide the TB Alliance's resource development, advocacy and policy, and community and stakeholder engagement strategies, which are focused on building global support for the development of promising new treatments to fight tuberculosis (TB).

"Never before has there been greater urgency to mobilize the resources to ensure new TB treatments in the pipeline can complete their development and reach those in need," said Mel Spigelman, President and CEO of the TB Alliance. "Willo Brock has extensive experience in bringing together partners to solve the world's most intractable problems. We welcome his skills and expertise to our team."

Mr. Brock comes to the TB Alliance with nearly 20 years of experience in international development, and has worked in more than 60 countries around the world. At WWF International, he led major donor relations for the US$100 million Campaign for a Living Planet, the organization's largest fundraising initiative. Prior to that, he was Director of Resource Development and Communications for Habitat for Humanity International. Mr. Brock started his career working for the Netherlands Ministry of Development in Pakistan.

"The work done by TB Alliance and its partners has the potential to save millions of lives, with a number of vitally important TB treatments that are very close to the finish line," said Willo Brock. "This is an opportunity to have an immediate impact on the lives of people in resource-poor nations."

Mr. Brock is a native of The Netherlands and holds a Masters of Business Administration from the Rotterdam School of Business at Erasmus University.

Every year, 1.3 million people worldwide die from TB. It is estimated that the bacteria that causes TB infects one-third of the world's population. The current treatment is inadequate, and resistance to today's drugs is growing. New, faster-acting, simpler drug regimens are critical to defeating TB.

About the TB Alliance

The Global Alliance for TB Drug Development (TB Alliance) is a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis. Through innovative science and with partners around the globe, we aim to ensure equitable access to faster, better TB cures that will advance global health and prosperity. The TB Alliance operates with funding from Australia Department of Foreign Affairs and Trade, Bill & Melinda Gates Foundation, European Commission, Global Health Innovative Technology Fund, Irish Aid, National Institute of Allergy and Infectious Disease, UNITAID, United Kingdom Department for International Development, United States Agency for International Development, and the United States Food and Drug Administration. For more information, please visit tballiance.org.

Contact:
Joanna Breitstein, +1 646-616-8613 or joanna.breitstein@tballiance.org

Photo - http://photos.prnewswire.com/prnh/20140730/131795


'/>"/>
SOURCE TB Alliance
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Columbia Laboratories Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis
2. Advinus Therapeutics, a TATA Enterprise, Meets Year 1 Milestone in Drug Discovery Alliance
3. New White Paper from Tuberous Sclerosis Alliance Assesses Visual Field Risks of Vigabatrin
4. Millennium Pharmacy Systems, Inc. SVP Pharmacy Operations & Chief Compliance Officer Appointed to 2014 Pharmacy Quality Alliance Board
5. Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials
6. Maverix Biomics Forms Strategic Co-Marketing Alliance with QIAGEN
7. Sorrento Therapeutics Enters into Antibody and Vaccine Development Alliance for the Prevention and Treatment of Obesity
8. Strategic Alliance Formed to Fight Counterfeit Drugs
9. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
10. Physician-Patient Alliance for Health & Safety: Maternal Morbidity on the Rise and Likely to Climb Even Higher
11. The Pershing Square Foundation Partners with The Sohn Conference Foundation To Launch $25 Million Cancer Research Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)...  The Corporate Whistleblower Center says, "We are ... clinics to call us anytime at 866-714-6466 if they ... in a substantial scheme to overbill Medicare. We ... employee of a medical equipment company if their ... medical practice groups with extra generous incentives to use, ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
Breaking Medicine Technology:
(Date:5/23/2017)... New York (PRWEB) , ... May 23, 2017 ... ... NextGen LifeLabs, a leading equipment provider in the modern ART laboratory, to provide ... Institute in Ft. Lauderdale, Florida. , NextGen LifeLabs, a MedTech Group Purchasing ...
(Date:5/23/2017)... MA (PRWEB) , ... May 23, 2017 , ... Orbita’s ... on Tuesday, May 23, 2017 in San Francisco. Titled Connected Health and IoT: ... Connected Home Event hosted by Parks Associates, a market research and consulting firm ...
(Date:5/23/2017)... San Francisco, California (PRWEB) , ... May 23, 2017 , ... ... released results of its new survey in an infographic on the current state of ... 900 U.S. respondents, familiar with anxiety, was conducted in April 2017 and benchmarked general ...
(Date:5/22/2017)... Kisco, NY (PRWEB) , ... May 22, 2017 , ... ... are urged to receive relaxing sedation dentistry in Mt. Kisco, NY from Advanced Endodontics ... be administered for a variety of treatments. One or more sedation methods may be ...
(Date:5/22/2017)... ... May 22, 2017 , ... An inventor from Columbia, S.C., ... pen. "My wife’s hand was damaged in a firework accident, so she couldn’t grip ... with manual problems." , He then designed and created a prototype for the HELPEN ...
Breaking Medicine News(10 mins):